Skip to main content
Journal cover image

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial

Publication ,  Conference
Becker, F; Dakin, H; Reed, SD; Li, Y; Leal, J; Gustavson, SM; Kartman, B; Wittbrodt, E; Gray, AM; Hernandez, AF; Holman, RR
Published in: DIABETOLOGIA
October 1, 2018

Duke Scholars

Published In

DIABETOLOGIA

EISSN

1432-0428

ISSN

0012-186X

Publication Date

October 1, 2018

Volume

61

Start / End Page

S366 / S366

Location

Berlin, GERMANY

Publisher

SPRINGER

Conference Name

54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Related Subject Headings

  • Endocrinology & Metabolism
  • 4206 Public health
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Becker, F., Dakin, H., Reed, S. D., Li, Y., Leal, J., Gustavson, S. M., … Holman, R. R. (2018). Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial. In DIABETOLOGIA (Vol. 61, pp. S366–S366). Berlin, GERMANY: SPRINGER.
Becker, F., H. Dakin, S. D. Reed, Y. Li, J. Leal, S. M. Gustavson, B. Kartman, et al. “Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial.” In DIABETOLOGIA, 61:S366–S366. SPRINGER, 2018.
Becker F, Dakin H, Reed SD, Li Y, Leal J, Gustavson SM, et al. Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial. In: DIABETOLOGIA. SPRINGER; 2018. p. S366–S366.
Becker, F., et al. “Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial.” DIABETOLOGIA, vol. 61, SPRINGER, 2018, pp. S366–S366.
Becker F, Dakin H, Reed SD, Li Y, Leal J, Gustavson SM, Kartman B, Wittbrodt E, Gray AM, Hernandez AF, Holman RR. Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial. DIABETOLOGIA. SPRINGER; 2018. p. S366–S366.
Journal cover image

Published In

DIABETOLOGIA

EISSN

1432-0428

ISSN

0012-186X

Publication Date

October 1, 2018

Volume

61

Start / End Page

S366 / S366

Location

Berlin, GERMANY

Publisher

SPRINGER

Conference Name

54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Related Subject Headings

  • Endocrinology & Metabolism
  • 4206 Public health
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences